BLUE
bluebird bio
BLUE
BLUE
Delisted
BLUE was delisted on the 30th of May, 2025.
83 hedge funds and large institutions have $411M invested in bluebird bio in 2014 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 39 increasing their positions, 17 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
83
Holders Change
+2
Holders Change %
+2.47%
% of All Funds
2.4%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
13
Increased
39
Reduced
17
Closed
9
Calls
$20K
Puts
$91K
Net Calls
-$71K
Net Calls Change
-$71K
Top Buyers
| 1 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
$16.1M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
$67.3M |
| 3 |
O
OrbiMed
New York
|
$6.57M |
| 4 |
Millennium Management
New York
|
$6.64M |
| 5 |
QF
QVT Financial
New York
|
$4.48M |
